Menu

All Items

Page 2 of 8  

Randomization Feb 2019

The Do's and Don'ts of Randomization in Clinical Trials

Jolee Graham, biostatistics director, Nicki Payne, director, IRT, and Katy Tam, director, biostatistics, discuss the components of successful randomization in research.

Read more...
 

Las Vegas Clinic Thumbnail

The Benefits of Glucose Clamp Procedures in Clinical Trials

Adalberto Barba Jr., director of clinical operations, early development, at PPD’s clinical pharmacology unit in Las Vegas, Nevada, discusses the site’s capabilities in glucose clamp studies.

Read more...
 

PatientAdvantage thumbnail

Our Enrollment Solutions: PatientAdvantage

A new way of thinking about clinical development and delivery

Read more...
 

Anonymization thumbnail

Balancing Scientific Value and Identification Risk in Anonymization

An overview of anonymization strategy for clinical documents in response to EMA Policy 0043 and Policy 0070

Read more...
 

FSP FSO Blog Thumb

Combining FSP and FSO Outsourcing Strategies

By Dave Agrella, vice president, functional service partnerships (FSP) and Timothy King, DrPH, executive director, FSP.

Read more...
Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.